Balloon catheter vascular injury of the alloxan-induced diabetic rabbit: the role of insulin-like growth factor-1.
Neointimal thickening following catheter injury is characterized, in part, by growth factor-induced vascular smooth muscle cell (VSMC) proliferation. It was hypothesized that a reduction in serum insulin-like growth factor-1 (IGF-1), characteristic of chemically-induced diabetes, would result in decreased VSMC proliferation and attenuate neointimal thickening. It was found that alloxan-treated New Zealand White rabbits exhibit varying degrees of glycemia. Rabbits classified as diabetic (glucose > or = 400 mg/dL) had significantly decreased serum concentration of IGF-1 (87.4+/-14 nmol/L vs. 170+/-14 nmol/L) and significantly decreased intimal/medial (I/M) ratios 2, 4, and 8 weeks after aortic injury compared to euglycemic rabbits (13.7+/-2, 21.1+/-2, 32.4+/-3 in euglycemics and 6.6+/-1, 14+/-2, 19+/-5 in diabetics, respectively). The I/M for high hyperglycemic animals (glucose 286-399 mg/dL) was comparable to diabetic animals yet their serum IGF-1 levels were normal rather than depressed. Vascular IGF-1 content similarly increased upon injury in both diabetic and euglycemic animals. In diabetic animals, proliferating cell nuclear antigen (PCNA) immunostaining was present by day 1 peaked by day 5 and returned to control by day 14. In euglycemic animals, staining by day 1 continued to increase through day 14. A similar increase in mitogen-activated protein kinase (MAPK) activity occurred from day 1 through day 5 in both diabetic and euglycemic animals. This is the first demonstration of an association between MAPK activity and VSMC proliferation following vascular injury in diabetic animals as previously reported in euglycemic animals. In conclusion, this study provides evidence against a direct effect of IGF-1 in the reduction in neointimal thickening, VSMC proliferation, and MAPK activity upon catheter injury in chemically-induced diabetic rabbits.
Schiller
N K
NK
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
McNamara
D B
DB
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002404:Catheterization; D002455:Cell Division; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000503:physiopathology*; D005263:Femoral Artery / Q000473:pathology* / Q000503:physiopathology; D007334:Insulin-Like Growth Factor I / Q000502:physiology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000473:pathology* / Q000503:physiopathology; D011817:Rabbits; D012016:Reference Values; D017539:Tunica Intima / Q000473:pathology* / Q000503:physiopathology
D001786:Blood Glucose; D007334:Insulin-Like Growth Factor I